BrightFocus Alzheimers Disease Research program has funded research into brain metabolism, inflammation, and novel therapeutic approaches that helped lay the groundwork for innovative discoveries like GLP-1s in Alzheimers disease
Most patients report meaningful appetite suppression within the first two weeks, though the exact timing varies based on individual metabolism, starting dose, and genetic factors affecting GLP-1 receptor sensitivity
Romero-Gmez M, Lawitz E, Shankar RR, Chaudhri E, Liu J, Lam RLH, et al
Why Consider Natural Herbs Instead of Synthetic GLP-1 Drugs
Semaglutide (marketed under the brand name Wegovy) and liraglutide (Saxenda) did lead to weight loss, but it was significantly less at 15% and 8%, respectively
The trade-off is that slower escalation means slower weight loss initially, but the improved tolerability often leads to better long-term adherence and outcomes